GEODE CAPITAL MANAGEMENT, LLC
Position in CTXR — Citius Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in CTXR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$130,399
-$91,142 QoQ
Shares Held
215,537
-12.4% QoQ
Ownership
0.785%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 43 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTXR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,415,676 across 520 Biotechnology names. CTXR ranks #429 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CTXR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,399 | 215,537 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $221,541 | 246,158 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $99,092 | 127,533 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $148,515 | 119,771 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $120,990 | 76,095 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $133,019 | 89,275 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $306,024 | 76,506 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $941,354 | 1,878,953 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $961,436 | 1,646,297 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,642,108 | 2,945,494 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,104,390 | 2,779,908 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,829,956 | 2,675,375 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,129,639 | 2,608,033 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,566,369 | 1,338,777 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,052,772 | 1,332,623 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,601,188 | 1,323,296 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,205,254 | 1,310,059 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,067,139 | 2,272,145 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,155,795 | 2,049,218 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,326,177 | 2,131,122 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,631,167 | 1,905,508 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,520,488 | 854,207 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $147,847 | 144,949 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $150,746 | 144,949 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $78,249 | 69,247 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||